Boyce S - Search Results

1

beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity.

Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJ, Hopkins R, Smith DW, Heavens RP, Dawson GR, Boyce S, Conner MW, Stevens KA, Slunt HH, Sisoda SS, Chen HY, Van der Ploeg LH. Zheng H, et al. Among authors: boyce s. Cell. 1995 May 19;81(4):525-31. doi: 10.1016/0092-8674(95)90073-x. Cell. 1995. PMID: 7758106 Free article.

2

Dawson GR, Seabrook GR, Zheng H, Smith DW, Graham S, O'Dowd G, Bowery BJ, Boyce S, Trumbauer ME, Chen HY, Van der Ploeg LH, Sirinathsinghji DJ. Dawson GR, et al. Among authors: boyce s. Neuroscience. 1999 Apr;90(1):1-13. doi: 10.1016/s0306-4522(98)00410-2. Neuroscience. 1999. PMID: 10188929

3

The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils.

Rupniak NM, Webb JK, Fisher A, Smith D, Boyce S. Rupniak NM, et al. Among authors: boyce s. Neuropharmacology. 2003 Mar;44(4):516-23. doi: 10.1016/s0028-3908(03)00023-6. Neuropharmacology. 2003. PMID: 12646288

4

Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.

Boyce S, Wyatt A, Webb JK, O'Donnell R, Mason G, Rigby M, Sirinathsinghji D, Hill RG, Rupniak NM. Boyce S, et al. Neuropharmacology. 1999 May;38(5):611-23. doi: 10.1016/s0028-3908(98)00218-4. Neuropharmacology. 1999. PMID: 10340299

5

Intra-amygdala injection of the substance P [NK(1) receptor] antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs.

Boyce S, Smith D, Carlson E, Hewson L, Rigby M, O'Donnell R, Harrison T, Rupniak NM. Boyce S, et al. Neuropharmacology. 2001 Jul;41(1):130-7. doi: 10.1016/s0028-3908(01)00051-x. Neuropharmacology. 2001. PMID: 11445193

6

Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo.

Harper S, Bilsland J, Young L, Bristow L, Boyce S, Mason G, Rigby M, Hewson L, Smith D, O'Donnell R, O'Connor D, Hill RG, Evans D, Swain C, Williams B, Hefti F. Harper S, et al. Among authors: boyce s. Neuroscience. 1999 Jan;88(1):257-67. doi: 10.1016/s0306-4522(98)00221-8. Neuroscience. 1999. PMID: 10051205

7

Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl.

Boyce S, Webb JK, Carlson E, Rupniak NM, Hill RG, Martin JE. Boyce S, et al. Exp Neurol. 1999 Jan;155(1):49-58. doi: 10.1006/exnr.1998.6873. Exp Neurol. 1999. PMID: 9918704

8

Nociception and inflammatory hyperalgesia in B2 bradykinin receptor knockout mice.

Boyce S, Rupniak NM, Carlson EJ, Webb J, Borkowski JA, Hess JF, Strader CD, Hill RG. Boyce S, et al. Immunopharmacology. 1996 Jun;33(1-3):333-5. doi: 10.1016/0162-3109(96)00101-4. Immunopharmacology. 1996. PMID: 8856178 No abstract available.

9

Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.

Seabrook GR, Sutton KG, Jarolimek W, Hollingworth GJ, Teague S, Webb J, Clark N, Boyce S, Kerby J, Ali Z, Chou M, Middleton R, Kaczorowski G, Jones AB. Seabrook GR, et al. Among authors: boyce s. J Pharmacol Exp Ther. 2002 Dec;303(3):1052-60. doi: 10.1124/jpet.102.040394. J Pharmacol Exp Ther. 2002. PMID: 12438527

10

Modulatory role for CCK-B antagonists in Parkinson's disease.

Boyce S, Rupniak NM, Tye S, Steventon MJ, Iversen SD. Boyce S, et al. Clin Neuropharmacol. 1990 Aug;13(4):339-47. doi: 10.1097/00002826-199008000-00009. Clin Neuropharmacol. 1990. PMID: 1976438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters